US 7,470,659 B2
Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM)
Daniel M. Schwartz, San Francisco, Calif. (US); Keith G. Duncan, San Francisco, Calif. (US); Kathy R. Bailey, San Francisco, Calif. (US); John P. Kane, Hillsborough, Calif. (US); and Brian Y. Ishida, Walnut Creek, Calif. (US)
Assigned to The Regents of the University of California, Oakland, Calif. (US)
Filed on Mar. 05, 2004, as Appl. No. 10/794,198.
Application 10/794198 is a continuation in part of application No. 10/428551, filed on May 02, 2003.
Application 10/428551 is a continuation in part of application No. 10/313641, filed on Dec. 06, 2002, abandoned.
Claims priority of provisional application 60/340498, filed on Dec. 07, 2001.
Claims priority of provisional application 60/415864, filed on Oct. 03, 2002.
Prior Publication US 2004/0266663 A1, Dec. 30, 2004
Int. Cl. A61K 38/02 (2006.01); A61K 38/17 (2006.01); A61K 31/685 (2006.01)
U.S. Cl. 514—2  [514/12; 514/13; 514/21; 514/78] 8 Claims
OG exemplary drawing
 
1. A method of treating macular degeneration in an individual, comprising the step of delivering a therapeutically effective amount of a liposome comprising ApoA-I to at least one tissue of the individual.